Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Elford

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Critical Reviews in Clinical Laboratory Sciences|January 24, 1998
The enzyme ribonucleotide reductase: target for antitumor and anti-HIV therapyT Szekeres, M Fritzer-Szekeres, H L Elford
Cancer Letters|August 27, 1998
Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cellsM S Myette, H L Elford, C R Chitambar
Journal of Medicinal Chemistry|May 1, 1979
Synthesis of hydroxy- and amino-substituted benzohydroxamic acids: inhibition of ribonucleotide reductase and antitumor activityB van't Riet, G L Wampler, H L Elford
Journal of Pharmaceutical Sciences|July 1, 1980
Structure-activity relationships of benzohydroxamic acid inhibitors of ribonucleotide reductaseB van't Riet, L B Kier, H L Elford
Cancer Research|March 1, 1979
New ribonucleotide reductase inhibitors with antineoplastic activityH L Elford, G L Wampler, B van't Riet
The Journal of Biological Chemistry|October 25, 1970
Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomasH L Elford, M Freese, E Passamani, et al.
Archiv Fur Mikrobiologie|January 1, 1970
Malate dismutation by DesulfovibrioJ D Miller, P M Neumann, L Elford, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 1, 1997
The new inhibitors of ribonucleotide reductase--comparison of some physico-chemical propertiesD Romanova, A Vachalkova, T Szekeres, et al.
Cancer Letters|May 12, 2005
Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing miceLadislav Novotny, Peter Rauko, Jan Liska, et al.
American Journal of Surgery|April 23, 2010
An expanding role for apolipoprotein E in sepsis and inflammationKelley Chuang, Erica L Elford, Jill Tseng, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Critical Reviews in Clinical Laboratory Sciences|January 24, 1998
The enzyme ribonucleotide reductase: target for antitumor and anti-HIV therapyT Szekeres, M Fritzer-Szekeres, H L Elford
Cancer Letters|August 27, 1998
Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cellsM S Myette, H L Elford, C R Chitambar
Journal of Medicinal Chemistry|May 1, 1979
Synthesis of hydroxy- and amino-substituted benzohydroxamic acids: inhibition of ribonucleotide reductase and antitumor activityB van't Riet, G L Wampler, H L Elford
Journal of Pharmaceutical Sciences|July 1, 1980
Structure-activity relationships of benzohydroxamic acid inhibitors of ribonucleotide reductaseB van't Riet, L B Kier, H L Elford
Cancer Research|March 1, 1979
New ribonucleotide reductase inhibitors with antineoplastic activityH L Elford, G L Wampler, B van't Riet
The Journal of Biological Chemistry|October 25, 1970
Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomasH L Elford, M Freese, E Passamani, et al.
Archiv Fur Mikrobiologie|January 1, 1970
Malate dismutation by DesulfovibrioJ D Miller, P M Neumann, L Elford, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 1, 1997
The new inhibitors of ribonucleotide reductase--comparison of some physico-chemical propertiesD Romanova, A Vachalkova, T Szekeres, et al.
Cancer Letters|May 12, 2005
Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing miceLadislav Novotny, Peter Rauko, Jan Liska, et al.
American Journal of Surgery|April 23, 2010
An expanding role for apolipoprotein E in sepsis and inflammationKelley Chuang, Erica L Elford, Jill Tseng, et al.
Pageof 7